Guangdong, China

Shuhui Chen

This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Joyo Pharmatech Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuhui Chen. Retrieved from https://idiyas.com/inventor/shuhui-chen-mnb5b98m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuhui Chen: Innovator in Macrocyclic Derivatives

Introduction

Shuhui Chen is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic derivatives. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Shuhui Chen holds a patent for a macrocyclic derivative and its use. The patent discloses a class of macrocyclic derivatives, specifically detailing a compound represented in formula (VI), along with its stereoisomers and pharmaceutically acceptable salts. This invention has the potential to impact various therapeutic applications.

Career Highlights

Shuhui Chen is currently employed at Guangzhou Joyo Pharmatech Co., Ltd., where she continues to push the boundaries of pharmaceutical research. Her work at the company reflects her commitment to innovation and excellence in the field.

Collaborations

Shuhui Chen collaborates with talented individuals, including her coworker Kai Zhou. Together, they contribute to the advancement of pharmaceutical technologies and research.

Conclusion

Shuhui Chen's contributions to the field of macrocyclic derivatives exemplify her role as an innovator in pharmaceuticals. Her patent and ongoing work at Guangzhou Joyo Pharmatech Co., Ltd. highlight her dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…